For U.S. residents only. Non-U.S. residents Novartis Pharma US
Learn About Novartis
   
Learn About Clinical Trials
                                   
Do you have Mantle Cell Lymphoma (MCL)?


man and woman lymphomaIf so, you may be eligible to participate in an important clinical research program. The Novartis clinical research study, Pillar-1, is investigating the drug RAD001 in patients with Mantle Cell Lymphoma (MCL).

You may be eligible to participate if you are:

  • 18 years of age or older
  • Diagnosed with Mantle Cell Lymphoma that has progressed despite treatment.

    Participants will be monitored closely throughout their treatment by highly trained doctors and nurses who specialize in Mantle Cell Lymphoma research and treatment.

    If you would like to see if you qualify to participate in a Novartis research study, click on the button below.

    Click here to see if you Qualify 

    • To view all Novartis clinical trials recruiting in the U.S., visit NovartisClinicalTrials.com

    Mailing List
    Sign up and receive information about clinical trials in your health-related areas of interest. For U.S. residents only.

     

    Novartis Pharma US